Marimed (MRMD) Land & Improvements (2015 - 2016)

Marimed's (MRMD) quarterly Land & Improvements came in at $686802.0 in Q3 2016, up 283.27% on a QoQ basis from $179196.0 in Q2 2016.

Marimed (MRMD) Land & Improvements (2015 - 2016) Analysis & Trends

Marimed (MRMD) has 2 years of Land & Improvements data on file, last reported at $686802.0 in Q3 2016.

On a quarterly basis, Land & Improvements changed N/A year-over-year to $686802.0 in Q3 2016; TTM through Sep 2016 was $686802.0, a N/A change from a year earlier, with the FY2015 full-year figure at $71488.0, changed N/A from the prior year.
Land & Improvements for Q3 2016 stood at $686802.0, up from $179196.0 in the prior quarter.
Over the last five years, Land & Improvements for MRMD reached as high as $686802.0 in Q3 2016 and fell as low as $71488.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Land & Improvements (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	-
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	-
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Marimed	23.85 Mn	14.02 Mn	15.28 Mn	-

Download Data